• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服胞磷胆碱治疗可改善青光眼患者的视觉通路功能。

Oral citicoline treatment improves visual pathway function in glaucoma.

作者信息

Rejdak Robert, Toczołowski Jerzy, Kurkowski Jacek, Kamiński Marek L, Rejdak Konrad, Stelmasiak Zbigniew, Grieb Paweł

机构信息

2nd Department of Ophthalmology, Medical University, Lublin, Poland.

出版信息

Med Sci Monit. 2003 Mar;9(3):PI24-8.

PMID:12640353
Abstract

BACKGROUND

Increased latency and reduced amplitude of visual evoked potentials (VEP), frequently encountered in ocular hypertension or open-angle glaucoma, suggest slowed neural conduction in the visual pathways. An improvement in VEP latency and amplitude has been reported following repeated intramuscular injections of citicoline, a neuroprotective drug. Our aim was to find whether citicoline given orally would produce a similar effect.

MATERIAL/METHODS: VEP latency and amplitude were measured in 21 glaucomatous eyes prior to and after two bi-weekly courses of citicoline taken orally in a dose of 1 gram/day. The treatment courses were separated by a two-week break; post-treatment VEP measurement was performed two weeks after the end of the second treatment.

RESULTS

62% of the eyes showed a response to the treatment, with VEP latency reduced from 123.5 (3.9 SEM) ms to 111.9 (1.9 SEM) ms (P=0.0008), and VEP amplitude increased from 6.56 (1.39 SEM) to 7.88 (1.16 SEM) (P=0.04).

CONCLUSIONS

Citicoline given orally improves visual evoked potentials in some glaucoma patients.

摘要

背景

在高眼压症或开角型青光眼中经常出现的视觉诱发电位(VEP)潜伏期延长和波幅降低,提示视觉通路中的神经传导减慢。据报道,反复肌肉注射神经保护药物胞磷胆碱后,VEP潜伏期和波幅有所改善。我们的目的是探究口服胞磷胆碱是否会产生类似效果。

材料/方法:对21只青光眼患眼在口服剂量为1克/天的胞磷胆碱、每两周一个疗程、共两个疗程之前和之后测量VEP潜伏期和波幅。两个疗程之间间隔两周;在第二个疗程结束后两周进行治疗后VEP测量。

结果

62%的患眼对治疗有反应,VEP潜伏期从123.5(标准误3.9)毫秒降至111.9(标准误1.9)毫秒(P = 0.0008),VEP波幅从6.56(标准误1.39)增至7.88(标准误1.16)(P = 0.04)。

结论

口服胞磷胆碱可改善部分青光眼患者的视觉诱发电位。

相似文献

1
Oral citicoline treatment improves visual pathway function in glaucoma.口服胞磷胆碱治疗可改善青光眼患者的视觉通路功能。
Med Sci Monit. 2003 Mar;9(3):PI24-8.
2
Cytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma.胞苷-5'-二磷酸胆碱(西地那非)可改善青光眼患者的视网膜和皮质反应。
Ophthalmology. 1999 Jun;106(6):1126-34. doi: 10.1016/S0161-6420(99)90269-5.
3
Evidence of the neuroprotective role of citicoline in glaucoma patients.胞磷胆碱在青光眼患者中的神经保护作用证据。
Prog Brain Res. 2008;173:541-54. doi: 10.1016/S0079-6123(08)01137-0.
4
Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.使用胞磷胆碱滴眼液进行治疗可增强开角型青光眼患者视网膜功能以及沿视觉通路的神经传导。
Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1327-40. doi: 10.1007/s00417-015-3044-9. Epub 2015 May 26.
5
Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study.脂质体剂型胞磷胆碱滴眼液治疗开角型青光眼对视功能和视觉通路神经传导的增强作用:一项初步电功能研究。
Adv Ther. 2019 Apr;36(4):987-996. doi: 10.1007/s12325-019-0897-z. Epub 2019 Feb 21.
6
Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.图形视网膜电图和视觉诱发电位在检测高眼压症和青光眼视觉功能障碍中的临床能力
Ophthalmology. 2006 Feb;113(2):216-28. doi: 10.1016/j.ophtha.2005.10.044. Epub 2006 Jan 10.
7
[The qualitative and quantitative diagnostic significance of P-VEP in the evaluation of glaucomatous visual function damage].[图形视觉诱发电位在青光眼视功能损害评估中的定性及定量诊断意义]
Zhonghua Yan Ke Za Zhi. 1991 Jan;27(1):25-9.
8
The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial.胞磷胆碱治疗在青光眼治疗中的神经保护作用——一项前瞻性治疗试验的6个月结果
Rom J Ophthalmol. 2019 Jul-Sep;63(3):222-230.
9
Neuroenhancement and neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A randomized pilot study.口服胞磷胆碱治疗非动脉炎性前部缺血性视神经病变模型的神经增强和神经保护作用:一项随机初步研究。
PLoS One. 2019 Jul 26;14(7):e0220435. doi: 10.1371/journal.pone.0220435. eCollection 2019.
10
[The effect of parenteral citicoline on visual functions and life quality of patients with primary open-angle glaucoma].[胃肠外注射胞磷胆碱对原发性开角型青光眼患者视觉功能和生活质量的影响]
Vestn Oftalmol. 2011 Sep-Oct;127(5):18-21.

引用本文的文献

1
Neuroprotective Effect of the Combination of Citicoline and CoQ10 in a Mouse Model of Ocular Hypertension.胞磷胆碱与辅酶Q10联合应用对高眼压小鼠模型的神经保护作用
Antioxidants (Basel). 2024 Dec 24;14(1):4. doi: 10.3390/antiox14010004.
2
Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies.青光眼神经保护的进展:药理学策略与新兴技术
Pharmaceuticals (Basel). 2024 Sep 25;17(10):1261. doi: 10.3390/ph17101261.
3
Efficacy of citicoline as a supplement in glaucoma patients: A systematic review.
胞磷胆碱作为青光眼患者补充剂的疗效:系统评价。
PLoS One. 2023 Sep 28;18(9):e0291836. doi: 10.1371/journal.pone.0291836. eCollection 2023.
4
CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial.胞二磷胆碱促进多发性硬化症的髓鞘再生:开展临床试验的必要性。
Neural Regen Res. 2023 Dec;18(12):2599-2605. doi: 10.4103/1673-5374.373671.
5
Citicoline: pharmacological and clinical review, 2022 update.胞磷胆碱:药理学和临床综述,2022 年更新。
Rev Neurol. 2022 Nov 30;75(s05):S1-S89. doi: 10.33588/rn.75s05.2022311.
6
Newer advances in medical management of glaucoma.青光眼的医学管理新进展。
Indian J Ophthalmol. 2022 Jun;70(6):1920-1930. doi: 10.4103/ijo.IJO_2239_21.
7
Effect of oral citicoline therapy on retinal nerve fiber layer and ganglion cell-inner plexiform layer in patients with primary open angle glaucoma.口服胞磷胆碱疗法对原发性开角型青光眼患者视网膜神经纤维层和神经节细胞-内丛状层的影响。
Int J Ophthalmol. 2022 Mar 18;15(3):483-488. doi: 10.18240/ijo.2022.03.17. eCollection 2022.
8
Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis.胞磷胆碱:一种用于多发性硬化症辅助治疗的候选药物。
Pharmaceuticals (Basel). 2021 Apr 2;14(4):326. doi: 10.3390/ph14040326.
9
Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review.眼科神经退行性疾病中的胞磷胆碱:综述
Pharmaceuticals (Basel). 2021 Mar 20;14(3):281. doi: 10.3390/ph14030281.
10
[The role of citicoline in glaucoma].[胞磷胆碱在青光眼治疗中的作用]
Ophthalmologe. 2021 May;118(5):439-448. doi: 10.1007/s00347-021-01362-z. Epub 2021 Mar 17.